Exenatide vs Semaglutide
Research Verdict
Semaglutide is the stronger research reference for the stated comparison criteria. Semaglutide: SUSTAIN and STEP Phase 3 programs, SELECT CVOT (HR 0.80 for MACE), ~15% weight loss.
Quick Answers
Which is better, Exenatide or Semaglutide?
Semaglutide is the stronger research reference for the stated comparison criteria. Semaglutide: SUSTAIN and STEP Phase 3 programs, SELECT CVOT (HR 0.80 for MACE), ~15% weight loss.
What is the key difference between Exenatide and Semaglutide?
Semaglutide achieves roughly 3x the weight loss of exenatide with demonstrated CV benefit; exenatide was the first-in-class GLP-1RA but has been superseded by next-generation agents.
Evidence Comparison
Semaglutide: SUSTAIN and STEP Phase 3 programs, SELECT CVOT (HR 0.80 for MACE), ~15% weight loss. Exenatide: EXSCEL CVOT neutral, ~3-5% weight loss. Semaglutide is the clearly superior agent across all major endpoints.
Evidence Context Favoring Exenatide
Historical or mechanistic comparisons, or cost-driven formulary decisions where generic exenatide availability matters.
Evidence Context Favoring Semaglutide
Nearly all clinical and research contexts - semaglutide has superior efficacy, CV outcomes, and weight loss data.
Side-by-Side Snapshot
| Evidence grade | Exenatide: Level A Semaglutide: Level A |
|---|---|
| Research status | Exenatide: FDA Approved Semaglutide: FDA Approved |
| Primary category | Exenatide: Weight Loss & Metabolic Semaglutide: Weight Loss & Metabolic |
| Cited studies | Exenatide: 3 Semaglutide: 6 |